-
Bullish Free Articles, Free Articles, Free Trade Alerts
Inovio Pharma Poised To Go On A Nice Run
Summary Inovio Pharma has a potential solution for the coronavirus. A lot of $4 call options were bought in yesterday’s trading session. Coronanvirus is making headlines just recently, and stocks like INO have a really good shot at running much higher. Inovio Pharma (INO) has a nice chart set up which we think is poised to […]
-
Bullish Premium Articles, Premium Articles, Premium Trade Alerts
FPRX Article Preview (Subscribers Only)
Summary Identifying undervalued developmental Biotech companies that have the potential for a turn-around story, swing trade and/or investment can often times be rewarding. Five Prime Pharma could be such a turn-around story with a deep pipeline and recent form 13D filed by BioValue Fund. The company has several assets with catalysts this year, notwithstanding that […]
-
Free Articles, Free Trade Alerts
4 Biotech Long Trades to Consider
Trades and commentary below; Trillium (TRIL) Looking for upside breaks of $1.25, pivot $1.50, upper end – $2. downside – $0.93 cents. Five Prime Pharma (FPRX) – Looking for upside $4.80 pivot to $4.99, upper end $5.23, downside $4.20 Aduro Biotech (ADRO) – Looking for upside breaks of $1.28 to $1.35 – pivots to upper end $1. 70, downside […]
-
$ALRN – Potential Cup And Handle Breakout Chart
Targeting 80 to 85 cents on cup and handle potential breakout here Phase 1b/2 dose-optimization data due 2Q 2020 for Small Cell Lung Cancer (SCLC). Moon shot here as company is targeting p53, so it’s a lotto ticket if you decide to hold thru data. Here’s the chart: I drew in white where I see the […]
-
Commentary Premium Articles, Premium Articles
Audio – $FPRX Initial Commentary
Introduction to $FPRX – Corrections Here are FPRX’s actual compounds in which per usual, I had the names and numbers all messed up – FPA150: B7H4 – More to say on this later FPT155: CD80-FC – Interesting, but no known efficacy yet thru 42MG dose. Mouse model suggests efficacy at a certain point, but very […]
-
Bullish Free Articles, Free Articles, Free Trade Alerts
Video Chart Reviews + Deep Commentary & More!
This is going to be an open post, so membership not required for this one, but will be moving forward. Membership is free and currently gives access everything we are into from here on out – you can join for free at THIS LINK (must have valid email address or site will auto delete). Additionally, we […]
-
Bullish Free Articles, Free Articles, Free Trade Alerts
Here’s Why I’m Back Into $ADAP
I have bought 10k shares again for this go-around with $ADAP; Avg around $1.33. Note: I have also been loading up a lot of $TRIL. Love the chart here as it’s showing me strong handed bullishness – targeting a move to $1,75. Yes, I know I often trade in and out but I look for […]
-
Bullish Free Articles, Free Articles
3 Biotech Charts We Are Buying
Eloxx Pharmaceuticals (ELOX) chart cup and handle + catalyst play, 1st cat is N6 for cystinosis 3rd or 4th week of Dec, Bigger one is N20 + in Jan for CF. Targeting $8. Higher before CF potential run-up in January. Chart above is clearly showing a potential cup and handle breakout as indicated as I’ve marked […]
-
Bullish Free Articles, Free Articles
Trillium Therapeutics Showing Signs Of Life – CD 47 Spec Play We Are Long In For a Trade
This will be a Seeking Alpha Blog only because it’s a dirt cheap micro cap. It’s a trade only we think is worthwhile with an outside shot at an acquisition. Summary Trillium Therapeutics trades at a mere 10 million dollar market cap. The main reason for this is prior management engaged in horrible financing and […]
-
Bullish Free Articles, Free Articles
The Biotech Sector Is Heating Up – 2 Names That May Join The Fray Soon
Karuna Therapeutics (NASDAQ:KRTX), NextCure (NASDAQ:NXTC), and Constellation Pharmaceuticals (NASDAQ:CNST) are but the latest examples of how the biotech sector has been heating up. All 3 of these names have seen very strong stock appreciation on early impressive data. KRTX just reported that its developmental drug “KarXT, designed for the treatment of acute psychosis in schizophrenia patients, demonstrated […]